Test Price
2,800 AED✅ Home Collection Available
ZP1 Gene Oocyte Maturation Defect Genetic Test in UAE – 2,800 AED
Executive Summary & Core Metrics
Clinical Excellence & Patient-Centric Service
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with expert result interpretation.
- Insurance: Direct Billing Verification – WhatsApp +971 54 548 8731 for instant confirmation.
Test Overview & Methodology
A targeted next-generation sequencing (NGS) genetic test that analyzes the entire coding region of the ZP1 gene to identify pathogenic mutations causing oocyte maturation arrest and female infertility. It delivers a definitive molecular diagnosis to guide fertility treatment planning, including personalized IVF protocols or donor egg considerations.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Covers all coding exons & splice sites, detects novel variants | Limited to known mutation hotspots only |
| Methodology | NGS (Next Generation Sequencing) | Capillary electrophoresis-based sequencing |
| Turnaround Time | 3 – 4 Weeks | 4 – 6 Weeks |
| Cost (AED) | 2,800 | ~3,500 (where available) |
Physician Insight & Safety Protocols
“As a clinical geneticist, I recognize the profound emotional toll of unexplained infertility. The ZP1 gene test provides a precise molecular answer for couples facing oocyte maturation arrest, enabling tailored IVF strategies and informed reproductive decisions. Genetic results should always be integrated with a comprehensive fertility assessment by your specialist.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory
⚠️ Do not discontinue any prescribed medication or fertility treatment without first consulting your physician. Abrupt cessation may adversely affect your clinical outcome.
Exclusion Criteria & Clinical Red Flags
- Test not suitable for individuals who received a blood transfusion or hematopoietic stem cell transplant within the last 3 months (risk of DNA interference).
- Acute febrile illness may compromise sample quality – reschedule after recovery.
- For minors (under 18 years), legal guardian consent is mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Immediate medical attention required: severe pelvic pain, heavy vaginal bleeding, or signs of infection (redness, swelling, warmth) at the venipuncture site. Contact your healthcare provider without delay.
Patient FAQ & Clinical Guidance
1. What is the ZP1 gene oocyte maturation defect test and how is it performed?
A highly accurate next-generation sequencing test analyzing the ZP1 gene for mutations causing oocyte maturation defects. The procedure requires a simple blood draw or extracted DNA sample after mandatory genetic counseling. The laboratory uses NGS technology to sequence the entire ZP1 gene, identifying pathogenic variants with results available in 3–4 weeks.
2. Who should consider this test and what are the clinical indications?
Women with unexplained infertility, recurrent IVF failure, or primary ovarian insufficiency should consider ZP1 genetic testing. The test is indicated when oocyte maturation arrest is suspected based on poor embryo development or empty follicle syndrome. Clinical geneticists, reproductive endocrinologists, and OB/GYNs can order it after a thorough fertility evaluation.
3. What preparation is required and are there any risks?
No special preparation; a simple blood draw or DNA sample is collected after genetic counseling. The test carries minimal risk – typical venipuncture discomfort or minor bruising. Fasting is not required. Patients must provide a detailed clinical history and family pedigree chart before sample collection.
4. How are results delivered and what follow-up is provided?
Results are delivered electronically through a secure patient portal within 3–4 weeks. A telephonic post-test clinical guidance session is included, during which the referring physician or our genetic consultant explains the findings, their clinical implications, and recommended next steps for fertility management.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All laboratory processes are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). Patient data is encrypted, access-controlled, and used solely for diagnostic purposes with explicit consent under the medical liability framework of Federal Decree-Law No. 4 of 2016.
Clinical & Logistical Metadata
| Test Name | ZP1 Gene Oocyte Maturation Defect Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | N97.8 |
| LOINC Code | 94086-1 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians